The role of stromal mast cells in the modification of CD4 +CD25+Foxp3 regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor;Rola komórek tucznych naciekaja̧cych guz w modyfikacji funkcji limfocytów regulatorowych CD4+CD25+Foxp 3, limfocytów Th17 oraz limfocytów cytotoksycznych Tc1 w rozwoju i progresji guza nowotworowego

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 408-416

  Starska, Katarzyna ^a   Brzezińska Błaszczyk, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cytotoxic lymphocytes Tc1; Mast cells; Regulatory T cells (CD4+CD25+Foxp3 +); Th17 lymphocytes; Tumor progression

Indexed keywords

CANCER INVASION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; MAST CELL; METABOLISM; NEOPLASM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

HUMANS; MAST CELLS; NEOPLASM INVASIVENESS; NEOPLASMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 79952731954     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Bachelet I., Levi-Schaffer F.: Mast cells as effector cells: a co-stimulating question. Trends Immunol., 2007;28:360-365 (Pubitemid 47082507)
2. Balkwill F., Charles K. A., Mantovani A.: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 2005;7:211-217 (Pubitemid 40568680)
3. Bischoff S. C., Gebhardt T.: Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease. Adv. Exp. Med. Biol., 2006;579:177-208
4. Brzezińska-Błaszczyk E., Misiak-Tłoczek A.: The regulation of mast cell migration. Part 2: mast cell chemoattractants. Postepy Hig. Med. Dosw., 2007;61:493-499
5. Brzezińska-Błaszczyk E., Wierzbicki M.: Mast cell Toll-like receptors (TLRs). Postepy Hig Med Dosw., 2010;64:11-21
6. Chora̧ży-Massalska M., Kontny E., Maśliński W.: Komórki regulatorowe i odpowiedź immunologiczna. Postepy Biol. Kom., 2006;33:771-789
7. Conti P., Castellani M. L., Kempuraj D., Salini V., Vecchiet J., Tetè S., Mastrangelo F., Perrella A., De Lutiis M. A., Tagen M., Theoharides T. C.: Role of mast cells in tumor growth. Ann. Clin. Lab. Sci., 2007;37:315-322 (Pubitemid 350105931)
8. Crivellato E., Ribatti D.: Involvement of mast cells in angiogenesis and chronic inflammation. Curr. Drug Targets Inflamm. Allergy, 2005;4:9-11 (Pubitemid 40584848)
9. Cumberbatch M., Dearman R. J., Griffiths C. E., Kimber I.: Langerhans cell migration. Clin. Exp. Dermatol., 2000;25:413-418
10. Dabiri S., Huntsman D., Makretsov N., Cheang M., Gilks B., Bajdik C., Gelmon K., Chia S., Hayes M.: The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod. Pathol., 2004;17:690-695 (Pubitemid 38715492)
11. Dawicki W., Jawdat D. W., Xu N., Marshall J. S.: Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J. Immunol., 2010;184:2116-2123
12. Dawicki W., Marshall J. S.: New and emerging roles for mast cells in host defence. Curr. Opin. Immunol., 2007;19:31-38 (Pubitemid 46073696)
13. de Paulis A., Annunziato F., Di Gioia L., Romagnani S., Carfora M., Beltrame C., Marone G., Romagnani P.: Expression of the chemokine receptor CCR3 on human mast cells. Int. Arch. Allergy Immunol., 2001;124:146-150 (Pubitemid 32304787)
14. Di Girolamo N., Indoh I., Jackson N., Wakefield D., McNeil H. P, Yan W., Geczy C., Arm J. P., Tedla N.: Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J. Immunol., 2006;177:2638-2650 (Pubitemid 44201023)
15. Duffy S. M., Cruse G., Brightling C. E., Bradding P.: Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur. J. Immunol., 2007;37:1653-1662 (Pubitemid 46947855)
16. Erdmann A. A., Gao Z. G., Jung U., Foley J., Borenstein T., Jacobson K. A., Fowler D. H.: Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood, 2005;105:4707-4714 (Pubitemid 40807293)
17. Fischer M., Juremalm M., Olsson N., Backlin C., Sundström C., Nilsson K., Enblad G., Nilsson G.: Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int. J. Cancer, 2003;107:197-201 (Pubitemid 37152897)
18. Galli S. J., Kalesnikoff J., Grimbaldeston M. A., Piliponsky A. M., Williams CM., Tsai M.: Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 2005;23:749-786 (Pubitemid 40563184)
19. Galli S. J., Nakae S., Tsai M.: Mast cells in the development of adaptive immune responses. Nat. Immunol., 2005;6:135-142 (Pubitemid 40268194)
20. Gonzalez-Espinosa C., Odom S., Olivera A., Hobson J. P., Martinez M. E., Oliveira-Dos-Santos A., Barra L., Spiegel S., Penninger J. M., Rivera J.: Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med., 2003;197:1453-1465 (Pubitemid 36682544)
21. Grimbaldeston M. A., Nakae S., Kalesnikoff J., Tsai M., Galli S. J.: Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol., 2007;8:1095-1104 (Pubitemid 47423757)
22. Grizzi F., Franceschini B., Chiriva-Internati M., Liu Y., Hermonat P. L., Dioguardi N.: Mast cells and human hepatocellular carcinoma. World J. Gastroenterol., 2003;9:1469-1473 (Pubitemid 36992334)
23. Huang B., Lei Z., Zhang G. M., Li D., Song C., Li B., Liu Y., Yuan Y., Unkeless J., Xiong H., Feng Z. H.: SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood, 2008;112:1269-1279
24. Ikeda T., Funaba M.: Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol. Lett., 2003;88:21-26 (Pubitemid 36835844)
25. Inamura H., Kurosawa M., Okano A., Kayaba H., Majima M.: Expression of the interleukin-8 receptors CXCR1 and CXCR2 on cord-blood-derived cultured human mast cells. Int. Arch. Allergy Immunol., 2002;128:142-150 (Pubitemid 34639023)
26. Juremalm M., Olsson N., Nilsson G.: Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem. Biophys. Res. Commun., 2002;297:480-485
27. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O. A., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., Akdis C. A.: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature, 2001;413:420-425 (Pubitemid 32928596)
28. Kalesnikoff J., Galli S. J.: New developments in mast cell biology. Nat. Immunol., 2008;9:1215-1223
29. Karin M.: NF-κB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol., 2009;1:a000141
30. Karin M., Lawrence T., Nizet V.: Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell, 2006;124:823-835 (Pubitemid 43261455)
31. Kawakami T., Galli S. J.: Regulation of mast-cell and basophil function and survival by Ig E. Nat. Rev. Immunol., 2002;2:773-786 (Pubitemid 37328717)
32. Kempuraj D., Papadopoulou N. G., Lytinas M., Huang M., Kandere-Grzybowska K., Madhappan B., Boucher W., Christodoulou S., Athanassiou A., Theoharides T. C.: Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology, 2004;145:43-48 (Pubitemid 38094499)
33. Kinet J. P.: The essential role of mast cells in orchestrating inflammation. Immunol. Rev., 2007;217:5-7
34. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., Ishizaka K.: An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol., 2000;164:3855-3861 (Pubitemid 30169844)
35. Krishnaswamy G., Ajitawi O., Chi D. S.: The human mast cell: an overview. Methods Mol. Biol., 2006;315:13-34
36. Krishnaswamy G., Kelley J., Johnson D., Youngberg G., Stone W., Huang S. K., Bieber J., Chi D. S.: The human mast cell: functions in physiology and disease. Front. Biosci., 2001;6:D1109-D1127
37. Kubo Y., Fukuishi N., Yoshioka M., Kawasoe Y., Iriguchi S., Imajo N., Yasui Y., Matsui N., Akagi M.: Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflamm. Res., 2007;56:70-75 (Pubitemid 46412011)
38. Kulbe H., Thompson R., Wilson J. L., Robinson S., Hagemann T., Fatah R., Gould D., Ayhan A., Balkwill F: The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res., 2007;67:585-592 (Pubitemid 46192196)
39. Kulka M., Metcalfe D. D.: TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol. Immunol., 2006;43:1579-1586
40. + Tregs and NKT cells: regulators regulating regulators. Trends Immunol., 2006;27:322-327
41. + T cells. J. Immunol., 2005;174:1073-1080 (Pubitemid 40094304)
42. Lawrence T.: Inflammation and cancer: a failure of resolution? Trends Pharmacol. Sci., 2007;28:162-165 (Pubitemid 46483717)
43. Lee S. H., Park H. H., Kim J. E., Kim J. A., Kim Y. H., Jun. CD., Kim S. H.: Allose gallates suppress expression of pro-inflammatory cytokines through attenuation of NF-κB in human mast cells. Planta Med., 2007;73:769-773
44. Li Z., Chen L., Qin Z.: Paradoxical roles of IL-4 in tumor immunity. Cell. Mol. Immunol., 2009;6:415-422
45. + regulatory T cells. J. Immunol., 2005;175:4180-4183 (Pubitemid 41361949)
46. Lin W. W., Karin M.: A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest., 2007;117:1175-1183 (Pubitemid 46718402)
47. Liu Y., Yamada H., Ochi J.: Immunocytochemical studies on endothelin in mast cells and macrophages in the rat gastrointestinal tract. Histochem. Cell Biol., 1998;109:301-307 (Pubitemid 28166146)
48. Lu L. F., Lind E. F., Gondek D. C, Bennett K. A., Gleeson M. W., Pino-Lagos K., Scott Z. A., Coyle A. J., Reed J. L., Van Snick J., Strom T. B., Zheng X. X., Noelle R. J.: Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature, 2006;442:997-1002 (Pubitemid 44330250)
49. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol., 2006;177:246-254 (Pubitemid 43939136)
50. Maltby S., Khazaie K., McNagny K. M.: Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim. Biophys. Acta, 2009;1796:19-26
51. Marshall J. S.: Mast-cell responses to pathogens. Nat. Rev. Immunol., 2004;4:787-799 (Pubitemid 39336295)
52. Matsushima H., Yamada N., Matsue H., Shimada S.: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol., 2004;173:531-541 (Pubitemid 38797381)
53. Maurer M., Theoharides T., Granstein R. D., Bischoff S. C, Bienenstock J., Henz B., Kovanen P., Piliponsky A. M., Kambe N., Vliagoftis H., Levi-Schaffer F, Metz M., Miyachi Y., Befus D., Forsythe P., Kitamura Y., Galli S.: What is the physiological function of mast cells? Exp. Dermatol., 2003;12:886-910
54. McCurdy J. D., Lin T. J., Marshall J. S.: Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol., 2001;70:977-984 (Pubitemid 33151136)
55. Mekori Y. A.: The mastocyte: the "other" inflammatory cell in immunopathogenesis. J. Allergy Clin. Immunol., 2004;114:52-57 (Pubitemid 39005117)
56. Mekori Y. A., Baram D.: Heterotypic adhesion-induced mast cell activation: biologic relevance in the inflammatory context. Mol. Immunol., 2002;38:1363-1367 (Pubitemid 35253778)
57. Merluzzi S., Frossi B., Gri G., Parusso S., Tripodo C., Pucillo C: Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood, 2010;115:2810-2817
58. Metz M., Grimbaldeston M. A., Nakae S., Piliponsky A. M., Tsai M., Galli S. J.: Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev., 2007;217:304-328 (Pubitemid 46718153)
59. Metz M., Maurer M.: Mast cells - key effector cells in immune responses. Trends Immunol., 2007;28:234-241 (Pubitemid 46654869)
60. Miettinen M., Lasota J.: KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl. Immunohistochem. Mol. Morphol., 2005;13:205-220 (Pubitemid 41209013)
61. Misiak-Tłoczek A., Brzezińska-Błaszczyk E.: Regulacja migracji komórek tucznych. Czȩść 1: Cza̧steczki adhezji miȩdzykomórkowej. Postepy Hig. Med. Dosw., 2007;61:485-492
62. Morgan R. A., Dudley M. E., Wunderlich J. R., Hughes M. S., Yang J. C, Sherry R. M., Royal R. E., Topalian S. L., Kammula U. S., Restifo N. P., Zheng Z., Nahvi A., de Vries C. R., Rogers-Freezer L. J., Mavroukakis S. A., Rosenberg S. A.: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science, 2006;314:126-129 (Pubitemid 44547756)
63. Nagasaka A., Matsue H., Matsushima H., Aoki R., Nakamura Y., Kambe N., Kon S., Uede T., Shimada S.: Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur. J. Immunol., 2008;38:489-499
64. Nakayama T., Yao L., Tosato G.: Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J. Clin. Invest., 2004;114:1317-1325 (Pubitemid 40385303)
65. Nilsson G., Butterfield J. H., Nilsson K., Siegbahn A.: Stem cell factor is a chemotactic factor for human mast cells. J. Immunol., 1994;153:3717-3723 (Pubitemid 24313877)
66. Noli C., Miolo A.: The mast cell in wound healing. Vet. Dermatol., 2001;12:303-313 (Pubitemid 33686158)
67. Okayama Y.: Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors. Chem. Immunol. Allergy, 2005;87:101-110 (Pubitemid 43093182)
68. Okayama Y., Kawakami T.: Development, migration, and survival of mast cells. Immunol. Res., 2006;34:97-115 (Pubitemid 43997964)
69. Okumura S., Kashiwakura J., Tomita H., Matsumoto K., Nakajima T., Saito H., Okayama Y.: Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcsRI. Blood, 2003;102:2547-2554 (Pubitemid 37193594)
70. Okumura S., Sagara H., Fukuda T., Saito H., Okayama Y.: FcsRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J. Allergy Clin. Immunol., 2005;115:272-279 (Pubitemid 40215089)
71. Olsson N., Piek E., Sundström M., ten Dijke P., Nilsson G.: Transforming growth factor-β-mediated mast cell migration depends on mitogenactivated protein kinase activity. Cell. Signal., 2001;13:483-490 (Pubitemid 32545449)
72. Olsson N., Taub D. D., Nilsson G.: Regulation of mast cell migration by TH1 and TH2 cytokines: identification of tumour necrosis factor-α and interleukin-4 as mast cell chemotaxins. Scand. J. Immunol., 2004;59:267-272 (Pubitemid 38429293)
73. Olsson N., Ulfgren A. K., Nilsson G.: Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann. Rheum. Dis., 2001;60:187-193 (Pubitemid 32260597)
74. Piliponsky A. M., Chen C. C., Grimbaldeston M. A., Burns-Guydish S. M., Hardy J., Kalesnikoff J., Contag C. H., Tsai M., Galli S. J.: Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am. J. Pathol., 2010;176:926-938
75. Rao K. N., Brown M. A.: Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. NY Acad. Sci., 2008;1143:83-104
76. Ribatti D., Crivellato E.: The controversial role of mast cells in tumor growth. Int. Rev. Cell Mol. Biol., 2009;275:89-131
77. Ribatti D., Crivellato E., Roccaro A. M., Ria R., Vacca A.: Mast cell contribution to angiogenesis related to tumour progression. Clin. Exp. Allergy, 2004;34:1660-1664 (Pubitemid 39551516)
78. Rojas I. G., Spencer M. L., Martinez A., Maurelia M. A., Rudolph M. I.: Characterization of mast cell subpopulations in lip cancer. J. Oral Pathol. Med., 2005;34:268-273 (Pubitemid 40524966)
79. Romagnani P., De Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., Romagnani S., Marone G.: Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am. J. Pathol., 1999;155:1195-1204 (Pubitemid 29488927)
80. Samayawardhena L. A., Hu J., Stein P. L., Craig A. W.: Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell. Signal., 2006;18:1447-1454 (Pubitemid 43832080)
81. Samayawardhena LA., Kapur R., Craig A. W.: Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells. Blood, 2007;109:3679-3686 (Pubitemid 46641716)
82. Sawada J., Itakura A., Tanaka A., Furusaka T., Matsuda H.: Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood, 2000;95:2052-2058 (Pubitemid 30151645)
83. Steinman R. M., Inaba K.: Myeloid dendritic cells. J. Leukoc. Biol., 1999;66:205-208 (Pubitemid 29379156)
84. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., Ogawa H.: Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest., 2002;109:1351-1359 (Pubitemid 34546900)
85. Taghon T., Yui M. A., Rothenberg E. V.: Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat. Immunol., 2007;8:845-855 (Pubitemid 47099037)
86. Tataroglu C., Kargi A., Ozkal S., Esrefoglu N., Akkoclu A.: Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung Cancer, 2004;43:47-54 (Pubitemid 38096291)
87. Theoharides T. C., Conti P.: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol., 2004;25:235-241 (Pubitemid 38501669)
88. Tlsty T. D., Coussens L. M.: Tumor stroma and regulation of cancer development. Annu. Rev. Pathol., 2006;1:119-150
89. Wang S. W., Oh C. K., Cho S. H., Hu G., Martin R., Demissie-Sanders S., Li K., Moyle M., Yao Z.: Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. J. Allergy Clin. Immunol., 2005;115:287-294 (Pubitemid 40215091)
90. Williams CM., Galli S. J.: Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med., 2000;192:455-462 (Pubitemid 30629171)
91. Woolhiser M. R., Brockow K., Metcalfe D. D.: Activation of human mast cells by aggregated IgG through Fc RI: additive effects of C3a. Clin. Immunol., 2004;110:172-180 (Pubitemid 38296707)
92. Yang H., Wei J., Zhang H., Lin L., Zhang W., He S.: Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF. BMC Cell Biol., 2009;10:37
93. Yoshioka M., Fukuishi N., Iriguchi S., Ohsaki K., Yamanobe H., Inukai A., Kurihara D., Imajo N., Yasui Y., Matsui N., Tsujita T., Ishii A., Seya T., Takahama M., Akagi M.: Lipoteichoic acid downregulates FcRI expression on human mast cells through Toll-like receptor 2. J. Allergy Clin. Immunol., 2007;120:452-461 (Pubitemid 47102373)
94. Yoshioka M., Fukuishi N., Kubo Y., Yamanobe H., Ohsaki K., Kawasoe Y., Murata M., Ishizumi A., Nishii Y., Matsui N., Akagi M.: Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol. Pharm. Bull., 2008;31:212-216 (Pubitemid 351198391)
95. Yu J. J., Gaffen S. L.: Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci., 2008;13:170-177 (Pubitemid 351594768)